NP
NTRP

NorthRock Partners’s Neurotrope, Inc. Common NTRP Stock Holding History

NorthRock Partners’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-104,000
Closed -$834K – 211
2019
Q2 		$834K Buy
104,000
+32,500
+45% +$219K 0.24% 22
2019
Q1 		$390K Hold
71,500
– – 0.1% 46
2018
Q4 		$255K Buy
+71,500
New +$433K 0.08% 74

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NorthRock Partners's NTRP Position: Q3 2019 in Review

NorthRock Partners sold out of Neurotrope, Inc. Common (NTRP) in Q3 2019, closing a stake of 104,000 shares — an estimated $834K sold.

NorthRock Partners first reported a position in NTRP in Q4 2018 and held it in 3 quarters. The position peaked at $834K in Q2 2019. 29 funds tracked by Wall St. Rank hold NTRP as of Q3 2019.

  • NorthRock Partners reported no remaining Neurotrope, Inc. Common position as of Q3 2019 after selling out during the quarter.
  • NorthRock Partners sold 104,000 Neurotrope, Inc. Common shares in Q3 2019, an estimated $834K.
  • NorthRock Partners first reported a position in Neurotrope, Inc. Common in Q4 2018 and held it in 3 quarters.
  • NorthRock Partners's Neurotrope, Inc. Common position peaked at $834K in Q2 2019.
  • 29 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2019.

Based on NorthRock Partners's 13F filing for Q3 2019, filed 12 Nov 2019.